B O O K - American College of Rheumatology

5:30 PM
1438. Mortality/Morbidity in Cardiac Neonatal Lupus and
Associated Maternal/Fetal Risk Factors.
Peter M. Izmirly 1 , Amit Saxena 1 , Zoey Smith 2 and Jill P. Buyon 1 ,
1
NYU School of Medicine, New York, NY, 2 NYU School of
Medicine
5:45 PM
1439. Methotrexate in Children with Juvenile Localized
Scleroderma: A Randomized, Double-Blind, Placebo-Controlled
Trial.
Francesco Zulian 7 , Cristina Vallongo 8 , Giorgia Martini 8 , Fernanda
Falcini 5 , Annalisa Patrizi 4 , Maria Alessio 3 , Francesco La Torre 6 ,
Mario Cutrone 1 , Anna Belloni-Fortina 8 , Mauro Paradisi 2 , Silvana
Martino 9 , Fabio Vittadello 8 and Giorgio Perilongo 8 , 1 Children’s
Hospital of Mestre, 2 Dermatology, IDI IRCCS, Rome, 3 University
Federico II Naples, 4 University of Bologna, 5 University of
Florence, Florence, Italy, 6 University of Messina, 7 University of
Padua, Padua, Italy, 8 University of Padua, 9 University of Turin
Sidney J. Marcus Auditorium
Rheumatoid Arthritis - Clinical Aspects: Outcomes
Associated with Biologic Therapy for RA II
Moderators: Eric L. Matteson, MD; Mayo Clinic; Rochester, MN
Joseph A. Markenson, MD, MPH; Hospital for Special Surgery;
New York, NY
4:30 PM
1440. Methotrexate but Not TNF-Blockers Reduces Immune
Response Following Pneumococcal Vaccination Using 7-Valent
Conjugate Pneumococcal Vaccine (Prevenar®) in Adult Patients
with Established Arthritis.
Meliha C. Kapetanovic 5 , Carmen Roseman 5 , Göran Jönsson 1 ,
Lennart Truedsson 4 , Tore Saxne 3 and Pierre Geborek 2 , 1 Dept
of Clinical Sciences Lund, Section of Infectious Diseases, Lund
University, Lund, Sweden, 2 Dept of Clinical Sciences Lund,
Section of Rheumatology, Lund University, Lund, Sweden,
3
Dept of Clinical Sciences Lund, Section of Rheumatology, Lund
University, Sweden, 4 Dept of Laboratory Medicine, Section of
Microbiology, Immunology and Glycobiology, Lund University,
Lund, Sweden, 5 Section of Rheumatology, Lund University, Lund,
Sweden
4:45 PM
1441. Lipid and Inflammation Parameters: A Translational,
Randomized Placebo-Controlled Study To Evaluate Effects of
Tocilizumab: The MEASURE Study.
Iain B. McInnes 7 , Janet S. Lee 6 , Wen Wu 6 , Jon T. Giles 5 , Joan
M. Bathon 5 , Jane E. Salmon 4 , Andre D. Beaulieu 2 , Christine E.
Codding 3 , Christian Delles 1 and Naveed Sattar 1 , 1 British Heart
Foundation, Glasgow, United Kingdom, 2 Centre de Rhumatologie
St-Louis, Montreal, QC, Canada, 3 Health Research of Oklahoma,
Oklahoma City, OK, 4 Hospital for Special Surgery, New York, New
York, NY, 5 Johns Hopkins University, Baltimore, MD, 6 Roche,
Nutley, NJ, 7 University of Glasgow, Glasgow, United Kingdom
5:00 PM
1442. Tumor Necrosis Factor-α Inhibitors and Reduced Risk of
Developing Diabetes in Patients with Rheumatoid Arthritis.
Jana Antohe 1 , Androniki Bili 1 , Jennifer A. Sartorius 2 , H. Lester
Kirchner 2 , Stephanie J. Morris 1 , Sorina Dancea 1 and Mary Chester
Wasko 3 , 1 Geisinger Health System, Danville, PA, 2 Geisinger Health
System, 3 Univ of Pittsburgh, Pittsburgh, PA
5:15 PM
1443. Superior Protection Against “Vulnerable” Coronary
Plaque in Asymptomatic TNFi-Responders vs. DMARD
Responders with Rheumatoid Arthritis (RA).
George A. Karpouzas 1 , Naser Ahmadi2, Tae-Young Choi 2 ,
Fereshteh Hajsadeghi 2 , Silvia Munoz 2 and Mathew Budoff 2 ,
1
Harbor-UCLA, Long Beach, CA, 2Harbor-UCLA
5:30 PM
1444. Discontinuation of TNF-Inhibitor Treatment in Clinical
Practice Has a Negative Impact on Radiographic Progression 2
Years after Initiation of Therapy. Results from the Nationwide
Danish DANBIO Registry.
Lykke M. Ørnbjerg 1 , Mikkel Østergaard 1 , Pernille Bøyesen 13 ,
Anja Thormann 1 , Ulrik Tarp 6 , Wolfgang Böhme 14 , Ditte
Dencker 14 , Hanne Lindegaard 16 , Uta Poulsen 15 , Anette Hansen 2 ,
Vibeke Ringsdal 5 , Anette Schlemmer 5 , Niels Graudal 10 , Anne
R. Andersen 12 , Jakob Espesen 4 , Gina Kollerup 7 , Torben G.
Christensen 11 , Randi Pelck 3 , Bente Glintborg 3 , Ole R. Madsen 2 ,
Dorte V. Jensen 8 , Ole Majgaard 9 and Merete L. Hetland 1 ,
1
DANBIO Registry and Depts. of Rheumatology, Copenhagen
University Hospitals at Hvidovre and Glostrup, Denmark,
2
Dept. of Internal Medicine and Rheumatology, Gentofte
University Hospital, Denmark, 3 Dept. of Internal Medicine,
Copenhagen University Hospital at Holbæk, Denmark, 4 Dept.
of Internal Medicine, Hospital Lillebaelt at Vejle, Denmark,
5
Dept. of Rheumatology, århus University Hospital at ålborg,
Denmark, 6 Dept. of Rheumatology, århus University Hospital,
Denmark, 7 Dept. of Rheumatology, Copenhagen University
Hospital at Frederiksberg, Denmark, 8 Dept. of Rheumatology,
Copenhagen University Hospital at Hørsholm, Denmark, 9 Dept.
of Rheumatology, Copenhagen University Hospital at Næstved,
Denmark, 10 Dept. of Rheumatology, Copenhagen University
Hospital at Rigshospitalet, Denmark, 11 Dept. of Rheumatology,
Copenhagen University Hospital at Slagelse, Denmark, 12 Dept. of
Rheumatology, Copenhagen University Hospitals at Hvidovre and
Glostrup, Denmark, 13 Dept. of Rheumatology, Diakonhjemmet
Hospital, Oslo, Norway, 14 Dept. of Rheumatology, Hospital
of South West Jutland at Esbjerg, Denmark, 15 Dept. of
Rheumatology, King Christian Xth Hospital, Gråsten, Denmark,
16
Dept. of Rheumatology, Odense University Hospital, Denmark
5:45 PM
1445. Immunogenicity in a 3-Year Follow-Up Cohort of
Adalimumab Treated Rheumatoid Arthritis Patients.
Geertje M. Bartelds 1 , Charlotte L. Krieckaert 1 , Michael T.
Nurmohamed 1 , Pauline van Schouwenburg 2 , Ben A. Dijkmans 3
and Gerrit J. Wolbink 1 , 1 Jan van Breemen Institute, 2 Sanquin
Research, 3 VU Medical Center
A314
Spondylarthritis and Psoriatic Arthritis: Pathogenesis,
Etiology, and Animal Models
Moderators: Walter P. Maksymowych, MD; University of Alberta;
Edmonton, AB, Canada
Maxime A. Breban, MD, PhD; Hôpital Ambroise Pare;
Courbevoie, France
4:30 PM
1446. Fungal beta-Glucan Triggers Spondyloarthropathy and
Crohn’s Disease in SKG Mice.
2010 Program Book 81
tuesday